-+ 0.00%
-+ 0.00%
-+ 0.00%

INNOVENT ANNOUNCES POSITIVE CHMP OPINION, RECOMMENDING ZYBRIVO® (SINTILIMAB) FOR FIRST-LINE TREATMENT OF NON-SQUAMOUS NON-SMALL CELL LUNG CANCER

Reuters·11/16/2026 00:00:00

Please log in to view news